RAPIRA
Jak stosować RAPIRA
Tłumaczenie AI
Ta strona ma charakter informacyjny i nie zastępuje konsultacji lekarskiej. Przed zastosowaniem jakiegokolwiek leku skonsultuj się z lekarzem. Jeśli objawy są poważne, skorzystaj z pilnej pomocy medycznej.
Pokaż oryginałTreść ulotki
- INSTRUCTIONS for medical use of the medicinal product AMMONIA SOLUTION 10%
- Composition
- Pharmaceutical form
- Main physical and chemical properties
- Pharmaco-therapeutic group
- Pharmacological properties
- Clinical characteristics
- Method of application and doses
- Overdose
- Side reactions
- Shelf life
- Storage conditions
- Packaging
- Release category
- Manufacturer
- Location of the manufacturer and its address
- Applicant
- Location of the applicant
INSTRUCTIONS for medical use of the medicinal product AMMONIA SOLUTION 10%
Composition
active substance: ammonia; 100 ml of solution contain 10 g of ammonia; excipient: purified water.
Pharmaceutical form
Solution for external use.
Main physical and chemical properties
Transparent, colorless, volatile, highly alkaline liquid with a pungent odor. During storage, the presence of sparkles and/or slight turbidity is allowed.
Pharmaco-therapeutic group
Agents that affect the respiratory system. ATC code R07A B.
Pharmacological properties
Pharmacodynamics
Ammonia solution belongs to medicinal products that irritate nerve endings. The mechanism of action of ammonia when inhaled is based on the reflex stimulation of the respiratory center through receptors of the upper respiratory tract - the endings of the trigeminal nerve.
When applied to the skin, it has an irritating and antimicrobial effect.
Pharmacokinetics
The preparation does not enter the bloodstream.
Clinical characteristics
Indications
Unconscious state, in case of insect bites.
Contraindications
Increased sensitivity to the medicinal product.
Interaction with other medicinal products and other types of interactions
Not established.
Special instructions
Local application is possible only on intact skin.
In case of accidental exposure to the mucous membrane of the eye, rinse with water several times (within 15 minutes with a 10-minute break) or 3% boric acid solution. Oils and ointments are not used. In case of exposure to the nose and throat, use 0.5% lemon acid solution or natural juices. If taken internally, drink water, fruit juice, milk, or better - 0.5% lemon acid solution or 1% acetic acid solution until the stomach contents are fully neutralized.
Do not violate the rules for using the medicinal product, as this can harm health.
Use during pregnancy or breastfeeding
During pregnancy and breastfeeding, the use of the preparation is possible only when the expected benefit to the mother outweighs the potential risk to the fetus or child.
Ability to affect the speed of reaction when driving vehicles or other mechanisms
Does not affect.
Method of application and doses
To stimulate the respiratory center as a first aid measure: a small piece of gauze or cotton wool, moistened with ammonia solution, is carefully brought to the nostrils for 0.5-1 second.
In case of insect bites, ammonia solution is applied externally in the form of compresses (procedure duration - up to 30 seconds).
Children
The preparation is not used in children under 3 years of age.
Overdose
Enhancement of side reaction symptoms. Symptomatic therapy.
Side reactions
When inhaling ammonia vapors, reflex respiratory arrest may occur.
With local application, irritation, dermatitis, eczema at the site of application, allergic reactions are possible.
In case of any adverse reactions, it is necessary to consult a doctor.
Shelf life
2 years.
The preparation cannot be used after the expiration date stated on the packaging.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 °C. Store in a place inaccessible to children.
Packaging
40 ml in a vial in a pack or without a pack, 100 ml or 200 ml in vials.
Release category
Without a prescription.
Manufacturer
Private Joint-Stock Company Pharmaceutical Factory "Viola".
Location of the manufacturer and its address
69063, Ukraine, Zaporizhzhia, Amosov Street, 75.
Applicant
Private Joint-Stock Company Pharmaceutical Factory "Viola".
Location of the applicant
69063, Ukraine, Zaporizhzhia, Amosov Street, 75.
- Kraj rejestracji
- Substancja czynna
- Wymaga receptyNie
- Producent
- Te treści mają charakter wyłącznie informacyjny i nie zastępują konsultacji lekarskiej.
- Zamienniki RAPIRAPostać farmaceutyczna: solution, 300mg/3mlSubstancja czynna: acetylcysteineProducent: Мефар Ілач Сан. А.Ш.Wymaga receptyPostać farmaceutyczna: tablets, 200 mgSubstancja czynna: acetylcysteineBez receptyPostać farmaceutyczna: tablets, effervescent tablets 600mgSubstancja czynna: acetylcysteineBez recepty
Odpowiedniki RAPIRA w innych krajach
Leki z tą samą substancją czynną dostępne w innych krajach.
Odpowiednik RAPIRA w Polska
Lekarze online w sprawie RAPIRA
Omów stosowanie RAPIRA, bezpieczeństwo i ocenę zasadności recepty zgodnie z obowiązującymi przepisami.
Często zadawane pytania
Bądź na bieżąco z Oladoctor
Informacje o nowych usługach, aktualizacjach produktu i przydatnych materiałach dla pacjentów.